Literature DB >> 21133695

Beyond biomarkers: an opportunity to address the 'pharmacodynamic gap' in pediatric drug development.

Gregory L Kearns.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21133695     DOI： 10.2217/bmm.10.106

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  5 in total

1.  Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach.

Authors:  John van den Anker; Karel Allegaert
Journal:  Expert Rev Clin Pharmacol       Date:  2012-01       Impact factor: 5.045

2.  Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology.

Authors:  Karel Allegaert
Journal:  World J Clin Pediatr       Date:  2012-08-08

3.  Perinatal pharmacology.

Authors:  John van den Anker; Karel Allegaert
Journal:  Semin Fetal Neonatal Med       Date:  2012-12-01       Impact factor: 3.926

4.  The clinical translation gap in child health exercise research: a call for disruptive innovation.

Authors:  Naveen Ashish; Marcas M Bamman; Frank J Cerny; Dan M Cooper; Pierre D'Hemecourt; Joey C Eisenmann; Dawn Ericson; John Fahey; Bareket Falk; Davera Gabriel; Michael G Kahn; Han C G Kemper; Szu-Yun Leu; Robert I Liem; Robert McMurray; Patricia A Nixon; J Tod Olin; Paolo T Pianosi; Mary Purucker; Shlomit Radom-Aizik; Amy Taylor
Journal:  Clin Transl Sci       Date:  2014-08-11       Impact factor: 4.689

Review 5.  Useful pharmacodynamic endpoints in children: selection, measurement, and next steps.

Authors:  Lauren E Kelly; Yashwant Sinha; Charlotte I S Barker; Joseph F Standing; Martin Offringa
Journal:  Pediatr Res       Date:  2018-04-18       Impact factor: 3.756
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.